At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Apr 30, 2026 at 20:00 ET
Two C-suite insiders at Apogee Therapeutics sold a combined $377K in stock over a 7-day window, representing less than 0.01% of the $6.2B market cap. These are routine, small-dollar sales with no material signal for the stock.
- CFO Jane Henderson sold 811 shares for $66K on 2026-05-01
- CMO Carl Dambkowski sold 3,700 shares for $311K on 2026-05-06 after derivative exercises
- Total open-market sales: $377K, or ~0.006% of market cap
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access